|
|
Volumn 170, Issue 6, 2013, Pages 681-682
|
|
Sustained Weight Loss after Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in an Obese Patient with Schizophrenia and Type 2 Diabetes
a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST;
HEMOGLOBIN A1C;
INSULIN ASPART;
LIRAGLUTIDE;
METFORMIN;
SIMVASTATIN;
DRUG DERIVATIVE;
GLUCAGON LIKE PEPTIDE 1;
GLUCAGON LIKE PEPTIDE 1 RECEPTOR;
GLUCAGON RECEPTOR;
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C PROTEIN, HUMAN;
NEUROLEPTIC AGENT;
ADD ON THERAPY;
ADULT;
BODY MASS;
CASE REPORT;
DRUG ABUSE;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG SELF ADMINISTRATION;
DRUG TOLERABILITY;
FEMALE;
HEBEPHRENIA;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LETTER;
MEDICAL RECORD;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT RESPONSE;
WEIGHT REDUCTION;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
DRUG POTENTIATION;
MIDDLE AGED;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCAGON-LIKE PEPTIDE 1;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
MIDDLE AGED;
OBESITY;
RECEPTORS, GLUCAGON;
SCHIZOPHRENIA;
WEIGHT LOSS;
|
|
EID: 84882262707
PISSN: 0002953X
EISSN: 15357228
Source Type: Journal
DOI: 10.1176/appi.ajp.2013.12101344 Document Type: Letter |
|
Times cited : (21)
|
|
References (3)
|
